189 related articles for article (PubMed ID: 11891941)
1. Importance of the treatment package time in surgery and postoperative radiation therapy for squamous carcinoma of the head and neck.
Rosenthal DI; Liu L; Lee JH; Vapiwala N; Chalian AA; Weinstein GS; Chilian I; Weber RS; Machtay M
Head Neck; 2002 Feb; 24(2):115-26. PubMed ID: 11891941
[TBL] [Abstract][Full Text] [Related]
2. Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer.
Ang KK; Trotti A; Brown BW; Garden AS; Foote RL; Morrison WH; Geara FB; Klotch DW; Goepfert H; Peters LJ
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):571-8. PubMed ID: 11597795
[TBL] [Abstract][Full Text] [Related]
3. Final Report of a Prospective Randomized Trial to Evaluate the Dose-Response Relationship for Postoperative Radiation Therapy and Pathologic Risk Groups in Patients With Head and Neck Cancer.
Rosenthal DI; Mohamed ASR; Garden AS; Morrison WH; El-Naggar AK; Kamal M; Weber RS; Fuller CD; Peters LJ
Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1002-1011. PubMed ID: 28721881
[TBL] [Abstract][Full Text] [Related]
4. Predictors of response and survival after concurrent chemotherapy and radiation for locally advanced squamous cell carcinomas of the head and neck.
Suntharalingam M; Haas ML; Van Echo DA; Haddad R; Jacobs MC; Levy S; Gray WC; Ord RA; Conley BA
Cancer; 2001 Feb; 91(3):548-54. PubMed ID: 11169937
[TBL] [Abstract][Full Text] [Related]
5. Combined modality treatment outcomes for head and neck cancer: comparison of postoperative radiation therapy at academic vs nonacademic medical centers.
George JR; Yom SS; Wang SJ
JAMA Otolaryngol Head Neck Surg; 2013 Nov; 139(11):1118-26. PubMed ID: 24051518
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant radiotherapy improves overall survival for patients with lymph node-positive head and neck squamous cell carcinoma.
Lavaf A; Genden EM; Cesaretti JA; Packer S; Kao J
Cancer; 2008 Feb; 112(3):535-43. PubMed ID: 18076014
[TBL] [Abstract][Full Text] [Related]
7. Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: a secondary analysis of RTOG 85-27.
Lee WR; Berkey B; Marcial V; Fu KK; Cooper JS; Vikram B; Coia LR; Rotman M; Ortiz H
Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):1069-75. PubMed ID: 9869231
[TBL] [Abstract][Full Text] [Related]
8. An analysis of factors influencing the outcome of postoperative irradiation for squamous cell carcinoma of the oral cavity.
Parsons JT; Mendenhall WM; Stringer SP; Cassisi NJ; Million RR
Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):137-48. PubMed ID: 9300748
[TBL] [Abstract][Full Text] [Related]
9. Is a surgical resection leaving positive margins of benefit to the patient with locally advanced squamous cell carcinoma of the head and neck: a comparative study using the intergroup study 0034 and the Radiation Therapy Oncology Group head and neck database.
Laramore GE; Scott CB; Schuller DE; Haselow RE; Ervin TJ; Wheeler R; al-Sarraf M; Gahbauer RA; Jacobs JR; Schwade JG
Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1011-6. PubMed ID: 8262821
[TBL] [Abstract][Full Text] [Related]
10. Treatment results and prognostic factors of advanced T3--4 laryngeal carcinoma: the University of California, San Francisco (UCSF) and Stanford University Hospital (SUH) experience.
Nguyen-Tan PF; Le QT; Quivey JM; Singer M; Terris DJ; Goffinet DR; Fu KK
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1172-80. PubMed ID: 11483326
[TBL] [Abstract][Full Text] [Related]
11. Risk-group definition by recursive partitioning analysis of patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy.
Langendijk JA; Slotman BJ; van der Waal I; Doornaert P; Berkof J; Leemans CR
Cancer; 2005 Oct; 104(7):1408-17. PubMed ID: 16130134
[TBL] [Abstract][Full Text] [Related]
12. Postoperative radiation of free jejunal autografts in patients with advanced cancer of the head and neck.
Cole CJ; Garden AS; Frankenthaler RA; Reece GP; Morrison WH; Ang KK; Peters LJ
Cancer; 1995 May; 75(9):2356-60. PubMed ID: 7712448
[TBL] [Abstract][Full Text] [Related]
13. Alternating chemoradiotherapy versus partly accelerated radiotherapy in locally advanced squamous cell carcinoma of the head and neck: results from a phase III randomized trial.
Corvò R; Benasso M; Sanguineti G; Lionetto R; Bacigalupo A; Margarino G; Pallestrini E; Merlano M; Vitale V; Rosso R
Cancer; 2001 Dec; 92(11):2856-67. PubMed ID: 11753959
[TBL] [Abstract][Full Text] [Related]
14. Patterns of recurrence after selective postoperative radiation therapy for patients with head and neck squamous cell carcinoma.
Murakami N; Matsumoto F; Yoshimoto S; Ito Y; Mori T; Ueno T; Tuchida K; Kashihara T; Kobayashi K; Harada K; Kitaguchi M; Sekii S; Umezawa R; Takahashi K; Inaba K; Igaki H; Itami J
BMC Cancer; 2016 Mar; 16():192. PubMed ID: 26951089
[TBL] [Abstract][Full Text] [Related]
15. Combined-modality therapy for squamous carcinoma of the buccal mucosa: treatment results and prognostic factors.
Fang FM; Leung SW; Huang CC; Liu YT; Wang CJ; Chen HC; Sun LM; Huang DT
Head Neck; 1997 Sep; 19(6):506-12. PubMed ID: 9278759
[TBL] [Abstract][Full Text] [Related]
16. Postoperative radiotherapy in head and neck carcinoma with extracapsular lymph node extension and/or positive resection margins: a comparative study.
Huang DT; Johnson CR; Schmidt-Ullrich R; Grimes M
Int J Radiat Oncol Biol Phys; 1992; 23(4):737-42. PubMed ID: 1618666
[TBL] [Abstract][Full Text] [Related]
17. Bioreductive alkylating agent porfiromycin in combination with radiation therapy for the management of squamous cell carcinoma of the head and neck.
Haffty BG; Son YH; Wilson LD; Papac R; Fischer D; Rockwell S; Sartorelli AC; Ross D; Sasaki CT; Fischer JJ
Radiat Oncol Investig; 1997; 5(5):235-45. PubMed ID: 9372546
[TBL] [Abstract][Full Text] [Related]
18. Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up.
Rapidis AD; Trichas M; Stavrinidis E; Roupakia A; Ioannidou G; Kritselis G; Liossi P; Giannakouras G; Douzinas EE; Katsilieris I
Oral Oncol; 2006 Aug; 42(7):675-84. PubMed ID: 16731029
[TBL] [Abstract][Full Text] [Related]
19. Accelerated hyperfractionated irradiation for advanced head and neck cancer: effect of shortening the median treatment duration by 13 days.
Leborgne F; Leborgne JH; Fowler J; Zubizarreta E; Mezzera J
Head Neck; 2001 Aug; 23(8):661-8. PubMed ID: 11443749
[TBL] [Abstract][Full Text] [Related]
20. Tolerability, toxicity, and temporal implications of transoral robotic surgery (TORS) on adjuvant radiation therapy in carcinoma of the head and neck.
Carpenter TJ; Kann B; Buckstein MH; Ko EC; Bakst RL; Misiukiewicz KJ; Posner MR; Genden EM; Gupta V
Ann Otol Rhinol Laryngol; 2014 Nov; 123(11):791-7. PubMed ID: 24847162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
